Radioterapia Paliativa para Cuidados Oncológicos em Fim de Vida
DOI:
https://doi.org/10.24950/Revisao/103/19/1/2020Palavras-chave:
Cuidados Paliativos, Cuidados Terminais, Neoplasias/radioterapia, RadioterapiaResumo
A radioterapia com intuito paliativo pode aliviar uma multiplicidade de sintomas relacionados com cancro avançado. O alívio dos sintomas pode ser medido nas primeiras 24-48 horas ou em semanas ou meses após a conclusão da radioterapia. A taxa óptima de utilização de radioterapia no final de vida é desconhecida, devendo o seu uso ser criterioso. Contudo, deverá ser incluída, dada a sua eficácia, nos doentes cuja sobrevida o permita e minorada naqueles com curta expectativa de vida. Os estudos demonstram que os oncologistas têm tendência a sobreprognosticar a sobrevida dos seus doentes solicitando tratamentos que não os vão beneficiar. Os índices prognósticos podem ser úteis em estimar o período de sobrevida e ajudar a orientar decisões terapêuticas relativamente a radioterapia paliativa em doentes com tempo de sobrevida po- tencialmente curto. Esta revisão pretende destacar os bene- fícios e indicações da radioterapia paliativa para cuidados oncológicos em fim de vida.
Downloads
Referências
Lopes AC, Martins JC. A Radioterapia Nos Cuidados Paliativos: perspectiva do radioterapeuta. [Tese de mestrado em Cuidados Paliativos- 6o curso]. Porto: Faculdade de Medicina da Universidade do Porto;2016.
Lutz S, Chow E. Palliative radiotherapy: past, present and future- where do we go from here? Ann Palliat Med. 2014;3:286-290. Doi: 10.3978/ j.issn 2224-5820.2014.10.04
Joshua A , Lutz ST, Chow E, Johnstone PA. Paliative Radiothepy at the End of Life: A Critical Review. CA Cancer J Clin. 2014;64:296-310. doi: 10.3322/caac.21242.
Hayman JA, Abrahamse PH, Lakhani I, Earle CC, Katz SJ. Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer. Int J Radiation Oncology Biol Phys. 2007;69:1001–7. doi: 10.1016/j.ijro- bp.2007.04.059.[PubMed][Cross Ref]
Huang J, Wai ES, Lau F, Blood PA. Palliative radiotherapy utilization for cancer patients at end of life in British Columbia: retrospective cohort study. BMC Palliative Care. 2014; 13:49. doi:10.1186/1472-684X-13-49.
Quintino VL. Avaliação da eficácia da radioterapia paliativa no controlo da dor em doentes com metástases ósseas. [Trabalho para a obtenção de título de especialista em radioterapia]. Lisboa: Instituto Politécnico de Lisboa; 2015.
Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P,et al. Palliative ra- diotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiation Oncol Biol Phys. 2011; 79:965–76. doi:10.1016/j.ijro- bp.2010.11.026.
Fine P. Palliative radiation therapy in end-of-life care: evidence-based utilization. Am J Hosp Palliative Med. 2002;19:166– 70. doi: 10.1177/104990910201900307.
Roa W, Brasher PM, Bauman G, Anthes M, Bruera E, Chan A, et al. Abbreviated course of radiation therapy in older patients with glio- blastoma multiforme: A prospective randomized clinical trial J Clin Oncol.2004;22:1583–88.
Chen AM, Vaughan A, Narayan S, Vijayakumar S. Palliative radiotion therapy for head and neck cancer:Towards an optimal fractionation scheme. Head Neck. 2008; 30:1586-91. doi: 10.1002/hed.20894.
Bedwinek JM, Lee J, Fineberg B, Ocwieza M. Prognostic indicatiors in patients with isolated local-regional recurrence of breast cancer. Cancer. 1981; 47:2232-5
Rodrigues G, Videtic GM, Sur R, Bezjak A, Bradley J, Hahn CA, et al. Palliative thoracic radiotherapyin lung cancer: An American Society for Ra- diation Oncology evidence-based clinical practice guideline. Pract Radiat Oncol. 2011;1:60-71.doi:10.1016/j.prro.2011.01.005.
Fairchild A, Harris K, Barnes E, Wong R, Lutz S, Bezjak A, et al. Palliative thoracic radiotherapy for lung cancer. A systematic review. J Clin Oncol. 2008; 26:4001-11. doi: 10.1200/JCO.2007.15.3312.
Javle M, Ailawadhi S, Yang GY, Nwogu CE, Schiff MD, Nava HR. Palliation of malignant dysphagia in esophageal cancer: A literature-based review. J Supot Oncol. 2006; 365-73
Kim MM, Rana V, Janjan NA, Das P, Phan AT, Delclos ME, et al. Clinical benefit of palliative radiation therapy in advanced gastric cancer. Acta Oncol. 2008;47.421-7.
Mosconi C, Renzulli M, Giampalma E, Galuppi A, Balacchi C, Brandi G, et al. Unresectable perihilar cholangiocarcinoma: Multimodal palliative treatment. Anticancer Res. 2013;33:2747-53.
Janjan NA, Breslin T, Lenzi R, Rich TA, Skibber J. Avoidance of colostomy placement in advanced colorectal cancer with twice weekly hypofractionated radiation plus continuous infusion 5-fluorouracil. J Pain Symptom Manage. 2000; 20:266-72.
Duchesne GM, Bolger JJ, Griffiths GO, Trevor Roberts J, Graham JD, Hoskin PJ, et al. A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: Results of medical research council trial BA09. Int J Radiat Oncol Biol Phys. 2000; 47:379-88.
Mishra SK, Laskar S, Muckaden MA, Mohindra P, Shrivastava SK, Dinshaw KA.Monthly palliative pelvic radiotherapy in advanced carcinoma of uterine cervix. J Cancer Res Ther. 2005; 1:208-12
Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P, et al. Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline. Int J Radiat Oncol BioLPhys. 2011; 79:965-76. doi: 10.1016/j.ijro- bp.2010.11.026.
Chow E, Harris K, Fan G, Tsao M, Sze WM.Palliative radiotherapy trials for bone metastases: A systematic review. J Clin Oncol 2007; 25:1423-36.
Chow E, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS, et al. Single versus multiple fractions of repeat radiation for painful bone metastases: A randomised, controlled, non-inferiority trial. Lancet Oncol. 2014; 15:164-71. doi: 10.1016/S1470-2045(13)70556-4.
van der Linden YM, Steenland E, van Houwelingen HC, Post WJ, Oei B, Marijnen CA, et al. Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: Results on survival in the Dutch Bone Metastasis Study. Radiother Oncol. 2006; 78:245-53.
Byrne TN. Spinal cord compression from epidural metastases. N Engl J Med. 1992; 327:614-9.
Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG. et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial. Lancet Oncol. 2009; 10:1037-44. doi: 10.1016/S1470-2045(09)70263-3.
Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, et al. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brainradiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resec- tion or radiosurgery: Quality-of-life results. J Clin Oncol. 2013; 31:65-72. doi: 10.1200/JCO.2011.41.0639.
Langley RE, Stephens RJ, Nankivell M, Pugh C, Moore B, Navani N, et al. Interim data from the Medical Research Council QUARTZ Trial: Does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? Clin Oncol. 2013,25:e23-e30. doi: 10.1016/j.clon.2012.11.002.
Ashby M. The role of radiotherapy in palliative care. J Pain Symptom Ma- nage. 1991 6: 380-8.
Lutz S, Korytko T, Nguyen J, Khan L, Chow E, Corn B. Palliative radiotherapy: when is it worth it and when is it not? Cancer J. 2010;16:473-82. doi: 10.1097/PPO.0b013e3181f28b4d.
Chow E, Davis L, Panzarella T, Hayter C, Szumacher E, Loblaw A, et al. Accuracy of survival prediction by palliative radiation oncologists. Int J Ra- diat Oncol Biol Phys. 2005; 61: 870-3.
Spencer K, Morris E, Dugdale E, Newsham A, Sebag-montefiore D, Turner R, et al. 30 day mortality in adult palliative radiotherapy – A retrospective population based study of 14,972 treatment episodes. Radiother Oncol.
; 115: 264–71.
Lutz ST, Jones J, Chow E. Role of radiation therapy in palliative care of the patient with cancer. J Clin Oncol. 2014; 32: 2913-9. doi: 10.1200/JCO.2014.55.1143.
Kapadia NS, Mamet R, Zornosa C, Niland JC, DÂ ́Amico TA, Hayman JA. Radiation therapy at the end of life in patients with incurable nonsmall cell lung cancer. Cancer.2012;118:4339-45.
Guadagnolo BA, Liao KP, Elting L, Giordano S, Buchholz TA ,Shih YC. Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States. J Clin Oncol.2013;31:80-7.
National Quality Measures Clearinghouse .External Beam Radiotherapy for Bone Metastases. [Accessed April 2,2014] Available from: http://www. qualitymeasures.ahrq.gov/content.aspx?id=47285.
Murphy JD, Nelson LM, Chang DT, Mell LK, Le QT. Patterns of care in palliative radiotherapy: a population-based study. J Oncol Pract.2013; 9:e220-e227.
Yeung H. Palliative Radiation Before Hospice: the Long and the Short of It. Presented at: American Academy of Hospice and Palliative Medicine Annual Assembly; March 12-15,2014; San Diego, CA.
Lavergne MR, Johnston GM, Gao J, Dummer TJ, Rheaume DE. Variation in the use of palliative radiotherapy at end of life: examining demographic, clinical, health service, and geographic factors in a population-based study. Palliat Med.2011; 25:101-10.
Gripp S, Moeller S, Boelke E, Schmitt G, Matuschek C, Asgari S, et al. Survival prediction in terminally ill cancer patients by clinical estimates, la- boratory tests, and self-rated anxiety and depression. J Clin Oncol.2007; 25:3313-20.
Gripp S, Mjartan S, Boelke E, Willers R. Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: reality or myth? Can- cer.2010; 116:3251-6.
Berger B, Ankele H, Bamberg M, Zips D.Patients who die during palliative radiotherapy: status survey. Strahlenther Onkol. 2014;190:217-20.
AndersonF, Dowing GM, Hill J. Palliative Performance Scale (PPS): a new tool. J Palliat Care. 1996; 12:5-11.
Morita T, Tsunoda J, Inoue S. The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer. 1999; 7: 128-33.
Pirovano M, Maltoni M, Nanni O, Marinari M, Indelli M, Zaninetta G, et al . A new Palliative Prognostic Score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage. 1999; 17: 231-9.
Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, et al. Prognostic factors in advanced cancer patients: evidence-based clinical recomendations - a study by the steering committee of the European Associations for Palliative Care. J Clin Oncol 2005; 23: 6240-8.
Krishnan M, Temel JS, Wright AA, Bernacki R, Selvaggi K, Balboni T. Predicting life expectancy in patients with advanced incurable cancer. J Support Oncol. 2013; 11: 68-74
Chow E, Davis L, Panzarella T, Hayter C, Szumacher E, Loblaw A, et al. Accuracy of survival prediction by palliative radiation oncologists. Int J Radiat Oncol Biol Phys. 2005; 61 870-3.
Chow E, Abdolell M, Panzarella T, Harris K, Bezjak A, Warde P, et al. A validation of a predictive model for survival in metastatic cancer patients attending na outpatient palliative radiotherapy clinic. Int J Radiat Oncol Biol Phys. 2009 ̧73: 280-7. doi: 10.1016/j.ijrobp.2008.03.019.
Chow E, Abdolell M, Panzarella T, Harris K, Bezjak A, Warde P, et al. Preditive model for survival in patients with advanced cancer. J Clin Oncol.2008; 26:5863-9. doi: 10.1200/JCO.2008.17.
Krishnan MS, Epstein-Peterson Z, Chen YH, Tseng YD, Wright AA, Temel JS, et al. Predicting life expectancy in patients with metastatic cancerre- ceiving palliative radiotherapy: The TEACHH model. Cancer. 2014; 120: 134-41. doi: 10.1002/cncr.28408.
Tseng YD, Krishnan MS, Sullivan AJ, Jones JA, Chow E, Balboni TA. How radiatiaon oncologists evaluate and incorporate life expectancy estimates into the treatment of palliative cancer patients: A survey-based study. Int J Radiant Oncol Biol Phys. 2013; 87:471-8. doi: 10.1016/j.ijro- bp.2013.06.2046.
Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assess- ment of palliative care patients. J Palliat Care. 1991;7:6-9.
Lutz S, Spencer C, Chow E, Janjan N, Connor S. Survey on use of radio- therapy in hospice care. J Clin Oncol. 2004; 22: 3581-6.
Downloads
Publicado
Como Citar
Edição
Secção
Licença
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Direitos de Autor (c) 2023 Medicina Interna
Acesso livre
